Verdence Capital Advisors LLC Viatris Inc Transaction History
Verdence Capital Advisors LLC
- $1.23 Billion
- Q3 2024
A detailed history of Verdence Capital Advisors LLC transactions in Viatris Inc stock. As of the latest transaction made, Verdence Capital Advisors LLC holds 16,453 shares of VTRS stock, worth $184,273. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,453
Previous 27,536
40.25%
Holding current value
$184,273
Previous $292,000
34.59%
% of portfolio
0.02%
Previous 0.03%
Shares
14 transactions
Others Institutions Holding VTRS
# of Institutions
1,091Shares Held
966MCall Options Held
2.69MPut Options Held
2.34M-
Vanguard Group Inc Valley Forge, PA141MShares$1.58 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.04 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$707 Million0.03% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az62.6MShares$702 Million4.18% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$546 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $13.6B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...